Recommendations for stroke management: First part: Organization of stroke care, stroke treatment and neurorehabilitation;Preporuke za zbrinjavanje bolesnika s moždanim udarom: Prvi dio: Organizacija skrbi za bolesnike s moždanim udarom, liječenje moždanog udara i neurorehabilitacija

Lijecnicki Vjesnik

Volumn 125, Issue 7-8, 2003, Pages 200-212

  Demarin, Vida ^a   Lovrenčić Huzjan, Arijana ^a   Šerić, Vesna ^a   Vargek Solter, Vesna ^a   Trkanjec, Zlatko ^a   Vuković, Vlasta ^a   Lupret, Velimir ^a   Kalousek, Miljenko ^a   Desyo, Drago ^a   Kadojić, Dragutin ^b   Lušić, Ivo ^c   Dikanovic, Marinko ^d   Vitas, Marija ^d  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

^d Odjel za Neurologiju   (Croatia)

Author keywords

Cerebrovascular accident diagnosis, therapy, rehabilitation; Croatia; Neurology organization and administration; Practice guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; BENZODIAZEPINE; CAPTOPRIL; CLONIDINE; CORTICOSTEROID; DIHYDRALAZINE; FIBRINOLYTIC AGENT; FLUDROCORTISONE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HEPARINOID; LABETALOL; MANNITOL; METOPROLOL; NEUROLEPTIC AGENT; NIFEDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; PARACETAMOL; PROPOFOL; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; TRANQUILIZER; URAPIDIL;

ANTIHYPERTENSIVE THERAPY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CROATIA; DISABILITY; ECONOMIC ASPECT; EPIDEMIC; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; INCIDENCE; NEUROLOGY; PRACTICE GUIDELINE; REVIEW;

CEREBROVASCULAR ACCIDENT; HUMANS;

EID: 10744226980     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Warlow CP. Epidemiology of stroke. Lancet 1997;352(Suppl. III):1-4.
2. Demarin V. Stroke - Present state and perspectives. Editorial. Perodicum Biologorum, 1995;2:95-7.
3. Hrvatski zdravstvenostatistički ljetopis za 1999. godinu. Zagreb: Hrvatski zavod za javno zdravstvo: 2000.
4. Bonita R, Broad JB, Beaglehole R. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-1991. Lancet 1993;342:1470-3.
5. Brainin M, Bornstein N, Boysen G, Demarin V. Acute neurological stroke care in Europe: results of the European Stroke Care Inventory. Europ J Neurol 1999;7:5-10.
6. Demarin V. Emerging strategies in the prevention and diagnosis of stroke. Acta clin Croat 1997;36(Suppl):7-17.
7. Demarin V, Lovrenčić-Huzjan A, Šerić V, Vargek-Solter V, Trkanjec Z, Vuković V, Lupret V, Kalousek M, De Syo D, Kadojić D, Dikanović M, Vitas M. Recommendations for stroke management. Acta clin Croat 2001; 40:127-54.
8. Langhorne P, Williams B, Gilcrist B. Do stroke units save lives? Lancet 1993;342:395-8.
9. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-81.
10. The HOPE Investigators: Effects of an ACE inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
11. MacMahon S, Neal B. Differences between blood-pressure-lowering drugs. Lancet 2000;356:352-3.
12. PROGRESS Collaborative Group: Randomised trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke of transient ishaemic attack. Lancet 2001;358:1033-41.
13. National Institute of Neurological Disorders and Stroke: rt-PA Stroke Study Group (NINDS): Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-7.
14. Demarin V i sur. Priručnik iz neurologije. Demarin V. (ur.). Bjelovar: Prosvjeta d.d, Bjelovar, 1998.
15. Aboderin I, Venables G, for the PAN European Consensus Meeting on Stroke Management. Stroke management in Europe. J Intern Med 1996; 240:173-80.
16. Adams H, Brott T, Crowell R, Furlan A et al. Guidelines for the management of patients with acute ischaemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:1901-14.
17. Brainin M. European Federation of Neurological Societies Task Force: Neurological acute stroke care: The role of European neurology. Eur J Neurol 1997;4:435-41.
18. Biller J, Feinberg W, Castaldo J, Whittemore A et al. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998;97:501-9.
19. Einhaupl K, Diener C, Hacke W, Hennerici M, Ringelstein B. Behandlung des akuten ischämischen Insults. Dt Arztebl 1999;17:1123-30.
20. European Ad Hoc Consensus Group. European strategies for early intervention in stroke. Cerebrovasc Dis 1996;6:315-24.
21. Feinberg W, Albers G, Barnett H, Biller J et al. Guidelines for the management of transient ischaemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischaemic Attacks of the Stroke Council of the American Heart Association. Circulation 1994;89:2950-65.
22. Broderick JP, Adams HP, Barsan W, Feinberg W et al. Guidelines for the management of spontaneous intracerebral haemorrhage. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1999;30:905-15.
23. Hacke W, Kaste M, Skyhoj Olsen T, Orgogozo J-M, Bogousslavsky J. European Stroke Initiative (EUSI) Recommendations for Stroke Management. The European Stroke Initiative Writing Committee. Europ J Neurol 2000; 7:607-23.
24. Gorelick P, Sacco R, Smith D, Alberts M et al. Prevention of first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999;281:1112-20.
25. WHO Task Force on Stroke and Other Cerebrovascular Disorders: Recommendations on stroke prevention, diagnosis and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke 1989; 20:1407-31.
26. Holloway RG, Benesch C, Rush SR. Stroke prevention: Narrowing the evidence-practice gap. Neurology 2000;54:1899-1906.
27. Bogousslavsky J (ed). Stroke prevention by the practitioner. Cerebrovasc Dis 1999;(Suppl 4):9.
28. Stroke Units Trialists Collaboration. A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke. Br Med J 1997; 314:1151-9.
29. Ronning O, Guldvog B. Stroke units versus general medical wards. I. Twelve and eighteen-month survival. Arandomised, controlled trial. Stroke 1998;29: 58-62.
30. Indredavik B, Slordahl S, Bakke F, Roksetz R, Haheim L. Stroke unit treatment: Long-term effects. Stroke 1997;28:1861-6.
31. Hacke W, Stingele R, Steiner T, Schuchardt V, Schwab S. Critical care of acute ischaemic stroke. Intensive Care Med 1995;21:856-62.
32. Brott T, Reed RL. Intensive care for acute stroke in the community hospital setting. Stroke 1989;20:694-7.
33. Vargek-Solter V, Demarin V, Rundek T. Prognostic evaluation of the acute stroke. Period Biolog, 1995;2:63-6.
34. Hacke W. Intensive care in acute stroke. Cerebrovasc Dis 1997;7(Suppl.3): 18-23.
35. Saito I, Segawa H, Shiokawa Y, Taniguchi M, Tsusumi K. Middle cerebral artery occlusion: Correlation of computed tomography and angiography with clinical outcome. Stroke 1987;18:863-8.
36. von Kummer R, Allen K, Holle R, Bozzao L et al. Acute stroke: Usefulness of early CT findings before thrombolytic therapy. Radiology 1997; 205:327-33.
37. Alberts MJ, Lyden PD, Zivin JA et al. Emergency brain resuscitation. Ann Intern Med 1995;122;622-7.
38. Markus HS. A prospective follow up of thunderclap headache mimicking subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54: 1117-8.
39. Wijdicks EFM, Kerkhoff H, Van Gijn, J. Long-term follow-up of 71 patients with thunderclap headache mimicking subarachoid haemorrhage. Lancet. 1988;2:68-70.
40. Allen CMC. Clinical diagnosis of the acute stroke syndrome. Q J Med 1984;208:515-23.
41. Alexandrov AV, Demarin V. Insonation techniques and diagnostic criteria for transcranial Doppler sonography. Acta clin Croat 1999;38:97-108.
42. Hodek-Demarin V, Hudolin Vi, Dordevic V, Thaller N. Liquid crystal thermography and Doppler-sonography in the prevention of Stroke. Medit J Soc Psychiatry 1980;2:123-9.
43. Demarin V. Doppler sonography in cerebrovascular disorders. U: Kurjak A. (ur). Ultrasound in Developing Countries. Textbook for Postgraduate Students. Zagreb: Mladost, 1986:621-42.
44. Demarin V. U: Barac B. (ur.) Neurologija. Zagreb: Naprijed, 1992.
45. Babikian VL, Feldmann E, Wechsler LR, Newell DW et al. Transcranial Doppler ultrasonography: Year 2000 update. J Neuroimaging 2000;10: 101-15.
46. Alexandrov AV, Demchuk AM, Felberg RA, Christou I et al. High rate of complete recanalization and dramatic clinical recovery during T-PA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000;31:610-4.
47. Podobnik-Sarkanji S, Demarin V, Rundek T, Lovrenčić-Huzjan A. Risk factors for carotid artery atherosclerosis. Acta clin Croat 1995;34:145-55.
48. Demarin V, Štikovac M, Thaller N. (eds). Doppler sonografija krvnih zila. Zagreb: Školska knjiga 1990.
49. Demarin V (ed). Moždani krvotok - klinički pristup. Zagreb: Naprijed 1994.
50. Lovrenčić-Huzjan A. The role of ultrasound in diagnosing nonatherosclerotic vasculopathies of the nervous system. Acta clin Croat 1998;37 (suppl. 1):68-72.
51. Alexandrov AV, Demchuk AM, Wein TH, Grotta JC. Yield of transcranial Doppler in acute cerebral ischaemia. Stroke 1999;30:1604-9.
52. Lovrenčić-Huzjan A, Bosnar-Puretić M, Vuković V, Malić M, Thaller N, Demarin V. Correlation of color Doppler of the carotid arteries and angiographic findings in patients with symptomatic carotid artery stenosis. Acta clin Croat 2000;39:215-20.
53. Rundek T, Demarin V, Niederkorn K, Vukovid V et al. Prevalence of intracranial emboli signals in patients with carotid and cardiac disease. Acta clin Croat 1995;34:137-43.
54. Demarin V, Rundek T, Huzjan A, Podobnik S. The accuracy of TCCD in evaluation of cerebral AV malformations. J Neuroimaging 1995;5:82.
55. Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984;60:37-41.
56. Zygmunt SC, Delgado-Zygmunt TJ. The haemodynamic effect of transcranial Doppler. Guided high-dose nimodipine treatment in established vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 1995; 135:179-85.
57. Grotta J, Pasteur W, Khwaja G, Hamel T, Hamel T, Fisher M, Ramirez A. Elective intubation for neurologic deterioration after stroke. Neurology 1995;45:640-44.
58. Scandinavian Stroke Study Group. Multicenter trial of haemodilution in acute ischaemic stroke: results in the total patient population. Stroke 1987;18:691-9.
59. Norris J. Effect of cerebrovascular lesions on the heart. Neurol Clin 1983; 1:87-101.
60. Kaste M, Somer H, Konttinen A. Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders. Br Heart J 1978;40:802-5.
61. Wagner KR, Kleinholz M, de Courten-Myers GM, Myers RE. Hyperglycaemic versus normoglycaemic stroke: Topography of brain metabolites, -intracellular pH, and infarct size. J Cereb Blod Flow Metab 1992;12:213-22.
62. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischaemic stroke. Stroke 1998;29:2455-60.
63. Reith J, Jorgensen H, Pedersen P, Nakayama H, Raaschou H, Jeppesen L, Olsen T. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality and outcome. Lancet 1996;347:422-5.
64. Grau A, Buggle F, Heindl S, Steichen-Wiehn C et al. Recent infection as a risk factor for cerebrovascular ischaemia. Stroke 1995;26:373-9.
65. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischaemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996;94:1167-74.
66. Hacke W, Kaste M, Fieschi C, von Kummer R et al. Randomised double-blind placebo-controlled trials of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-51.
67. Multicenter Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Lancet 1995;46:1509-14.
68. Multicenter Acute Stroke trial - European Study Group (MAST-E). Thrombolytic therapy with streptokinase in acute ischaemic stroke. New Engl J Med 1996;335:145-50.
69. Donnan GA, Davis SM, Chambers BR, Gates PC et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995;345:578-79.
70. Furlan A, Higashida R, Wechsler L, Schulz G. PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromoembolisms. Initial Trial Results The PROACT II Investigators. Stroke 1999;30:234.
71. Hacke W, Zeumer H, Ferbert A, Bruckmann H, Del Zoppo G. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216-22.
72. Brandt T, von Kummer R, Muller-Kupper W, Hacke W. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996;27:875-81.
73. Sherman D, for the STAT Writers Group. Defibrinogenation with Viprinex (ancrod) for the treatment ofacute, ischaemic stroke. Stroke 1999;30:234.
74. Chinese Acute Stroke Trial (CAST). Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1999;349:1641-9.
75. Chen ZM, Sandercock P, Pan HCH, Counsell C et al. On behalf of the CAST and IST collaborative groups. Indications for early aspirin use in acute ischaemic stroke. A combined analysis of 40 000 randomised patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000;31:1240-9.
76. Swanson R. Intravenous heparin for acute stroke. What can we learn from the megatrials? Neurology 1999;52:1746-50.
77. Bath PHM, Iddenden R, Bath FJ. A meta-analysis of randomised controlled trials. Stroke 2000;31:1770-8.
78. Stand T. Evaluation of long-term outcome and safety after haemodilution therapy in acute ischaemic stroke. Stroke 1992;23:657-62.
79. Italian Acute Stroke Study Group. Haemodilution in acute stroke. Results of the Italian haemodilution trial. Lancet 1988;8581:318-21.
80. The Haemodilution in Stroke Study Group. Hypervolemic haemodilution treatment of acute stroke. Results of a randomised multicenter trial using pentastarch. Stroke 1989;20:312-23.
81. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators. Phase II Studies of the Glycine Antagonist GV150526 in Acute Stroke: The North American Experience. Stroke 2000;31:358-65.
82. Samsa GP, Matchar DB. Have randomised controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles. Stroke 2001;32:669-74.
83. Brott T, Broderick J, Kothari R, Barsan W et al. Early haemorrhage growth in patients with intracerebral haemorrhage. Stroke 1997;28:1-5.
84. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P et al. Effect of dexamethasone in primary supratentorial intracerebral haemorrhage. N Engl J Med 1987;316:1229-33.
85. Tellez H, Bauer R. Dexamethasone as treatment in cerebrovascular disease, 1: a controlled study in intracerebral haemorrhage. Stroke 1973;4:541-6.
86. Yu YL, Kumana CR, Lauder IJ, Cheung YK et al. Treatment of acute cerebral haemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomised trial. Stroke 1992;23:967-71.
87. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoidal haemorrhage: an update. Ann Neurol. 1983;14:599-608.
88. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurismal subarachnoid hemorrhage. Stroke 1985;16:562-72.
89. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr. Predicting cerebral ischaemia after aneurismal subarachnoid haemorrhage: influences and clinical condition, CT results, and antifibrinolytic therapy: a report of the Cooperative Aneurysm Study. Neurology 1987;37:1586-91.
90. Petruk KC, West M, Mohr G, Weir BK et al. Nimodipine treatment in poor grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505-17.
91. Pickard JD, Murray GD, Illingworth R, Shaw MD et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoidal haemorrhage: British aneurysm nimodipine trial. Br Med J 1989;298:636-42.
92. Haley EC, Kassell NF, Torner JC. A randomised controlled trial of high-dose intravenous nicardipine in aneurismal subarachnoid haemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:537-47.
93. Haley EC, Kassell NF, Torner JC. A randomised trial of nicardipine in subarachnoid haemorrhage: angiographic and transcranial Doppler ultrasound results: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:548-53.
94. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid haemorrhage: response to hypervolemic haemodilution and arterial hypertension. Stroke 1987;18:365-72.
95. Levy M, Gianotta S. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991;75:27-31.
96. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: effects of high dose methylprednisolon on delayed cerebral ischaemia in patients at high risk for vasospasm after aneurismal subarachnoid haemorrhage. Neurosurgery 1987;21:157-60.
97. Eskridge JM, Newell DW, Pendleton GA. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1990;1:387-99.
98. Higashida RT, Halbach VV, Cahan LD, Brant-Zawadski M et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989;71:648-53.
99. Hasan D, Wijdicks EFM, Vermeulen M. Hyponatremia is associated with cerebral ischaemia in patients with aneurismal subarachnoid haemorrhage. Ann Neurol 1990;27:106-8.
100. Soloman RA, Post KD, McMurty JG. Depression of circulating blood volume in patients after subarachnoidal haemorrhage: implications for the treatment of symptomatic vasospasm. Neurosurgery 1984;15:354-61.
101. Wijdicks EFM, Vermeulen M, van Brummelen P, van Gijin J. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurismal subarachnoid haemorrhage. Clin Neurol Neurosurg 1988;90:209-14.
102. Rajshekar V, Harbaugh RE. Results of routine ventriculostomy with external ventricular drainage for acute hydrocephalus following subarachnoid haemorrhage. Acta Neurochir (Wien) 1992;115:8-14.
103. Bogdahn U, Lau W, Hassel W, Gunreben G, Martens HG, Brawanski A. Continuous-pressure controlled, external ventricular drainage for treatment of acute hydrocepahlus: evaluation of risk factors. Neurosurgery 1992;31:898-903.
104. Black PM. Hydrocephalus and vasospasm after subarachnoid haemorrhage from ruptured intracranial aneurysms. Neurosurgery 1986;18:12-6.
105. Torner JC, Kassell NF, Wallace RB, Adams HP Jr. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. Neurosurgery 1981;9:506-51.
106. Kassell NF, Torner JC, Haley EC, Jane JA et al. The International Cooperative Study on The Timing of Aneurysm Surgery, Part 1: Overall management results. J Neurosurg 1990;73:18-36.
107. Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP. The International Cooperative Study on The Timing of Aneurysm Surgery, Part 2: Surgical results. J Neurosurg 1990;73:37-47.
108. Todd NF, Tocher JL, Jones PA, Miller JD. Outcome following aneurysm wrapping: a 10-year follow-up review of clipped and wrapped aneurysms. J Neurosurg 1989;70:841-46.
109. Torner JC, Nibbelink DW, Burmeister LF. Statistical comparisons of end results of a randomised treatment study. In: Sahs AL, Nibbelink DW, Torner JC (eds). Aneurismal Subarachnoidal Haemorrhage: Report of the Cooperative Study. Baltimore: Urban & Schwarzenberg; 1981:249-76.
110. Taylor W, Miller JD, Todd NV. Long-term outcome following anterior cerebral artery ligation for ruptured anterior communicating artery aneurysms. J Neurosurg 1991;74:51-4.
111. Vermuelen M, Lindsay KW, Murray GD, Cheah F et al. Antifibrinolytic treatment in subarachnoid haemorrhage. N Engl J Med 1984;311:432-7.
112. Guglielmi G, Vinuela F, Duckwiler G, Dion J et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 1992;77:515-24.
113. Hacke W, Schwab S, Horn M, Spranger M, DeGEorgia M, von Kummer R. Malignant middle cerebral artery territory infarction. Clinical course and prognostic signs. Arch Neurol 1996;53:309-15.
114. Rieke K, Schwab S, Krieger D, von Kummer R, Aschoff A, Schuchardt V, Hacke W. Decompressive surgery in space-occupying hemispheric infarction. Results of an open, prospective trial. Crit Care Med 1995;23: 1576-87.
115. Schwab S, Schwarz S, Spranger M, Keller E, Betram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461-6.
116. Heros RC. Surgical treatment of cerebellar infarction. Stroke 1992;23: 937-8.
117. Horner J, Massey EW. Silent aspiration following stroke. Neurology 1988;38:317-9.
118. Wagenaar RC. Effects of stroke rehabilitation. In: Kaufman T (ed.) Rehabilitation of the geriatric patient. New York: Churchill Livingstone, 2000;130-4.
119. Kwakkel G, Wagenaar RC, Kollen B, Lankhorst GH. Predicting disability in stroke: A critical review of the literature. Age and Ageing 1996; 25:479-89.
120. Wagenaar RC, Meijer OG. Effects of stroke rehabilitation (1 and 2): A critical review of the literature. J Rehabiltat Sci, 1991;4:61-73,96-108.